[HTML][HTML] Advances in acute myeloid leukemia: recently approved therapies and drugs in development
Simple Summary Acute myeloid leukemia (AML) is one of the most common types of
leukemia in adults, with an average first diagnosis at age 68, and has historically carried …
leukemia in adults, with an average first diagnosis at age 68, and has historically carried …
[引用][C] Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
M Stanchina, D Soong, B Zheng-Lin, JM Watts… - …, 2020 - scholarship.miami.edu
Abstract anti-body drug conjugate hedgehog FLT3 novel therapeutics AML IDH1
immunotherapy BCL2 Review CD47 CD33 CD123
immunotherapy BCL2 Review CD47 CD33 CD123
[PDF][PDF] Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
M Stanchina, D Soong, B Zheng-Lin, JM Watts, J Taylor - pdfs.semanticscholar.org
Acute myeloid leukemia (AML) is a genetically heterogeneous malignancy comprised of
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development.
M Stanchina, D Soong, B Zheng-Lin, JM Watts… - …, 2020 - search.ebscohost.com
Abstract Simple Summary: Acute myeloid leukemia (AML) is one of the most common types
of leukemia in adults, with an average first diagnosis at age 68, and has historically carried …
of leukemia in adults, with an average first diagnosis at age 68, and has historically carried …
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development.
M Stanchina, D Soong, B Zheng-Lin, JM Watts, J Taylor - Cancers, 2020 - go.gale.com
Acute myeloid leukemia (AML) is one of the most common types of leukemia in adults, with
an average first diagnosis at age 68, and has historically carried poor prognosis due to …
an average first diagnosis at age 68, and has historically carried poor prognosis due to …
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
M Stanchina, D Soong, B Zheng-Lin, JM Watts, J Taylor - Cancers, 2020 - cir.nii.ac.jp
抄録< jats: p> Acute myeloid leukemia (AML) is a genetically heterogeneous malignancy
comprised of various cytogenetic and molecular abnormalities that has notoriously been …
comprised of various cytogenetic and molecular abnormalities that has notoriously been …
[引用][C] Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
M Stanchina, D Soong, B Zheng-Lin, JM Watts… - Cancers (Web …, 2020 - jglobal.jst.go.jp
Roboz, GJ; DiNardo, CD; Stein, EM; de Botton, S.; Mims, AS; Prince, GT; Altman, JK;
Arellano, ML; Donnellan, W.; Erba, HP; et al. Ivosidenib induces deep durable remissions in …
Arellano, ML; Donnellan, W.; Erba, HP; et al. Ivosidenib induces deep durable remissions in …
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
M Stanchina, D Soong, B Zheng-Lin, JM Watts… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a genetically heterogeneous malignancy comprised of
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …
[HTML][HTML] Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
M Stanchina, D Soong, B Zheng-Lin, JM Watts, J Taylor - Cancers, 2020 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a genetically heterogeneous malignancy comprised of
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development.
M Stanchina, D Soong, B Zheng-Lin, JM Watts, J Taylor - Cancers, 2020 - europepmc.org
Acute myeloid leukemia (AML) is a genetically heterogeneous malignancy comprised of
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …
various cytogenetic and molecular abnormalities that has notoriously been difficult to treat …